5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.75▼ | 8.92▼ | 8.87▼ | 8.87▼ | 9.22▼ |
MA10 | 8.80▼ | 8.92▼ | 8.97▼ | 8.97▼ | 8.48▲ |
MA20 | 8.90▼ | 8.99▼ | 9.00▼ | 9.28▼ | 5.78▲ |
MA50 | 8.92▼ | 9.01▼ | 8.79▼ | 8.02▲ | 4.95▲ |
MA100 | 8.98▼ | 8.81▼ | 9.24▼ | 5.57▲ | N/A |
MA200 | 9.00▼ | 9.24▼ | 9.10▼ | 5.16▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.023▼ | -0.028▼ | -0.037▼ | -0.184▼ | 0.386▲ |
RSI | 25.647▼ | 37.671▼ | 41.883▼ | 49.080▼ | 62.881▲ |
STOCH | 1.905▼ | 35.000 | 22.928 | 26.560 | 74.384 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -78.363▼ | -32.173 |
CCI | -121.451▼ | -174.440▼ | -156.478▼ | -48.902 | 53.308 |
Tuesday, August 05, 2025 04:11 AM
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...
|
Thursday, July 24, 2025 08:42 AM
Sagimet Biosciences (NASDAQ:SGMT) stock rises as Canaccord Genuity endorses the company's liver drug denifanstat as it launches coverage with a Buy. Read more here.
|
Thursday, July 24, 2025 08:42 AM
Sagimet Biosciences (NASDAQ:SGMT) traded higher on Thursday after Canaccord Genuity launched its coverage with a Buy recommendation, citing the potential of its lead asset denifanstat, targeted at ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 9.23 | 9.30 | 8.71 | 8.73 | 330,145 |
07/08/25 | 9.46 | 9.46 | 8.8004 | 9.05 | 417,430 |
06/08/25 | 8.97 | 9.24 | 8.78 | 9.17 | 463,813 |
05/08/25 | 8.55 | 9.3752 | 8.37 | 8.96 | 888,656 |
04/08/25 | 8.35 | 8.69 | 8.2748 | 8.45 | 578,411 |
01/08/25 | 8.60 | 8.81 | 7.99 | 8.25 | 825,117 |
31/07/25 | 8.87 | 9.1881 | 8.6031 | 8.69 | 648,880 |
30/07/25 | 9.26 | 9.60 | 8.75 | 8.89 | 573,144 |
29/07/25 | 10.22 | 10.265 | 9.25 | 9.27 | 694,046 |
28/07/25 | 10.24 | 10.46 | 9.4001 | 10.23 | 1,124,800 |
|
|
||||
|
|
||||
|
|